OOIR: Observatory of International Research

Papers

(The H4-Index of Drug and Alcohol Dependence is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
EFFECTS OF SOCIAL DEFEAT STRESS EXPOSURE ON SPATIAL MEMORY PERFORMANCE IN SOCIALLY MONOGAMOUS MALE PRAIRIE VOLES	287
EXPLORING ASSOCIATIONS BETWEEN TRADITIONAL GENDER NORMS AND PRE-IMMIGRATION SEXUAL RISK BEHAVIORS AMONG MALE & FEMALE RECENT LATINO/A IMMIGRANTS	162
SEX AND GENOTYPE DEPENDENT DRUG-INDUCED DOPAMINE RELEASE IN ADOLESCENT CHRNA6 3’-UTR RATS	128
Drug use and needle sharing among adolescents and young adults in Nigeria: A cross-sectional secondary analysis of data from a multi-site clinical trial	117
Comparing Racial and Ethnic Differences on Access to Wellness Services for People in Substance Use Treatment	82
Receiving Medications for Opioid Use Disorder in Maryland Correctional Facilities and at a Community-Based Low-Threshold Buprenorphine Program Post-Release: Patient and Staff Perspectives	78
Sex Differences in Contextual Cocaine Seeking Behavior are Driven by Noradrenergic Signaling to the Dorsal Hippocampus	68
UTILIZING INNOVATIVE APPROACHES TO ENHANCE THE FULL POTENTIAL OF SUBSTANCE USE DATA TO BENEFIT MINORITIZED POPULATIONS	63
Misuse Potential of Medicinal Ketamine in Real-World Clinical Contexts, Part 1: Patients With At-Home Prescribed Ketamine	57
Risky Polysubstance Use Among People who Use Opioids in a Community-Based Study	55
Clinical Translation of the HR/LR Model of SUD Propensity	54
Guanfacine Reduces Drug Craving, Stress and Increases the Number of Abstinence Days in Women With Polysubstance Use Disorder (PSUD): A Pilot 2-Site Clinical Study	54
BRIDGING THE GAP: PRACTICAL AND ETHICAL CONSIDERATIONS ON THE UTILITY OF ARTIFICIAL INTELLIGENCE IN SUBSTANCE USE DISORDERS	53
Evaluation of Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use via Ecological Momentary Assessments	52
Provider Perspectives on Child Protective Services Reporting for Perinatal Patients With Opioid Use Disorder	51
Beyond Rest: Unraveling the Nexus of Sleep Deficiency, Environment, Control, and their Influence on Opioid Use Disorder Treatment Outcomes	50
The Association between Poly-victimization and Opioid Misuse Among Justice-Involved Adolescents	49
Adolescent Gender Diversity and Substance Use Exposure: A Mediating Role of Peer Victimization	49
Characterizing Substance Use Disorder on Reddit Through Network Analysis and Transitions of Use Between Opioids, Cannabis, and Other Drugs	47
The Effects of Acupuncture Stimulation at Shenmen (HT7) on Brain Stimulation Reward in Rats	42
A randomized pilot trial of two forms of behavioral economics intervention to improve engagement in buprenorphine-naloxone treatment among patients with opioid use disorder	42
Chronic Oral Dosing of Cannabidiol (CBD) With and Without low Doses of Delta-9-Tetrahydrocannabinol (Δ-9-THC)	42
Development of the Subject-Rated Comprehensive Drug Withdrawal Scale (CDWS) to Evaluate the Physical Dependence Potential of Investigational Drugs	40
A Comparative Study of Behavioral Effects of Novel Designer Drugs in Male Rodents	39
Racial and Ethnic Disparities in Telehealth and Emergency Department Use Among Women With Substance Use Disorder during the COVID-19 Pandemic	39

Factors Associated With Self-Directed Discharge Among Hospitalized Individuals With a Substance Use Disorder	38
Determination of Yohimbine's Reinforcing Actions in Male and Female Rats	37
Denial of Prescription Pain Medication Among People Who Use Drugs in Vancouver, Canada	36
Comparative Effectiveness of Intranasal Naloxone and Nalmefene in a Translational Model Assessing Reversal of Cardiac Arrest Induced by Synthetic Opioid Overdose	35
Nalfurafine is Aversive at Analgesic Doses - Non-Clinical Evidence to Indicate It is Not an Atypical Kappa Opioid Receptor Agonist	35
Pharmacology of Newer Synthetic Cannabinoids at the CB1 Receptor	34
Risk of COVID-19 Hospitalization and Death in Patients on Chronic Opioid Therapy and With Opioid Use Disorder	34
Editorial Board	33
Screening in Trauma for Opioid Misuse Prevention (STOMP): Results from a prospective cohort of victims of traumatic injury	33
Assessment of the Publication Trends of the Harm Reduction Studies over 40 Years	33
The moderating role of resilience in the relationship between experiences of COVID-19 response-related discrimination and disinformation among people who inject drugs	33